K

Kailera Therapeutics Inc
D

KLRA

14.810
USD
-0.05
(-0.34%)
مفتوح الان
حجم التداول
13,511
الربح لكل سهم
-4
العائد الربحي
-
P/E
-7
حجم السوق
1,916,133,531
المقالات
المزيد

العنوان: Kailera Therapeutics Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.